Our Centre has world-leading capabilities in surgical and radiotherapy technologies, cancer detection and device technologies, and is at the forefront in the development of novel clinical interventions for patient benefit. Importantly, generation of early evidence on clinical utility, human factors and cost effectiveness are key factors on ensuring success, redirecting development as well as abandoning unpromising technologies at an early stage. However, there are several challenges for the adoption of innovations, often associated with bridging the expertise of engineers with the requirements of the healthcare market. We wish to guide our technologies along the adoption pathways. To do so, we have established a group of specialists actively supporting clinical positioning and human factors mapping, patient engagement, using dissemination and implementation sciences.

Thus, translating novel technologies, devices and treatments into clinical practice requires a multidisciplinary effort to navigate the research ethics, regulatory approval processes and support to enable optimal clinical positioning. These problems are often insurmountable hurdles preventing innovations from attracting external commercial and venture capital funding required for progression to clinical use. To address the challenges outlined above, we our team facilitate translation of the most promising innovations along the clinical approval pathway to maximise the likelihood of clinical adoption.